These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28413580)

  • 1. Pet Imaging and its Application in Cardiovascular Diseases.
    Li Z; Gupte AA; Zhang A; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2017; 13(1):29-33. PubMed ID: 28413580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future clinical applications of cardiac positron emission tomography.
    Ohira H; Mc Ardle B; Cocker MS; deKemp RA; Dasilva JN; Beanlands RS
    Circ J; 2013; 77(4):836-48. PubMed ID: 23486164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET as a cardiovascular and metabolic research tool.
    Knuuti J; Nuutila P
    Ann Med; 1999 Dec; 31(6):450-6. PubMed ID: 10680861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine.
    Tingen HSA; van Praagh GD; Nienhuis PH; Tubben A; van Rijsewijk ND; Ten Hove D; Mushari NA; Martinez-Lucio TS; Mendoza-Ibañez OI; van Sluis J; Tsoumpas C; Glaudemans AWJM; Slart RHJA
    Br J Radiol; 2023 Dec; 96(1152):20230704. PubMed ID: 37786997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New radiotracers for imaging of vascular targets in angiogenesis-related diseases.
    Hong H; Chen F; Zhang Y; Cai W
    Adv Drug Deliv Rev; 2014 Sep; 76():2-20. PubMed ID: 25086372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for modeling pathophysiological processes in vivo.
    Hendrikse NH; Luurtsema G; van der Veldt AA; Lubberink M
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):717-25. PubMed ID: 18729023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and modeling of myocardial metabolism.
    Obrzut S; Jamshidi N; Karimi A; Birgersdotter-Green U; Hoh C
    J Cardiovasc Transl Res; 2010 Aug; 3(4):384-96. PubMed ID: 20559785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
    Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
    Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Myocardial Metabolism with Hybrid PET Imaging: Instrumentation, Concepts, and Workflows.
    Nekolla SG; Rischpler C
    Curr Pharm Des; 2016; 22(1):96-104. PubMed ID: 26548306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders.
    Yoshinaga K; Chow BJ; dekemp RA; Thorn S; Ruddy TD; Davies RA; DaSilva JN; Beanlands R
    Curr Pharm Des; 2005; 11(7):903-32. PubMed ID: 15777243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.
    Heo GS; Sultan D; Liu Y
    Q J Nucl Med Mol Imaging; 2020 Mar; 64(1):4-20. PubMed ID: 32077667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Cardiovascular Diseases Research Using Animal Models and PET Radioisotope Tracers.
    Wargocka-Matuszewska W; Uhrynowski W; Rozwadowska N; Rogulski Z
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of macrophages in cardiovascular diseases.
    Li X; Rosenkrans ZT; Wang J; Cai W
    Am J Transl Res; 2020; 12(5):1491-1514. PubMed ID: 32509158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of myocardial metabolism.
    Herrero P; Gropler RJ
    J Nucl Cardiol; 2005; 12(3):345-58. PubMed ID: 15944540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Radiopharmaceuticals for Personalized Medicine.
    Sharma S
    Curr Drug Targets; 2016; 17(16):1894-1907. PubMed ID: 27440185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging. A new approach to nuclear cardiology.
    Dobrucki LW; Sinusas AJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):106-15. PubMed ID: 15724140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Trends Cardiovasc Med; 2020 Jan; 30(1):11-19. PubMed ID: 30824163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging and Positron Emission Tomography Approaches to Imaging Vascular and Cardiac Inflammation.
    Amsallem M; Saito T; Tada Y; Dash R; McConnell MV
    Circ J; 2016 May; 80(6):1269-77. PubMed ID: 27151335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET and SPECT in cardiovascular molecular imaging.
    Dobrucki LW; Sinusas AJ
    Nat Rev Cardiol; 2010 Jan; 7(1):38-47. PubMed ID: 19935740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.